Status: current, Defined. Date: 31-May 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4389551000168116 | Nucala (mepolizumab 100 mg / 1 mL) injection, 1 x 1 mL syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4389561000168119 | Nucala 100 mg/mL injection, 1 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nucala 100 mg/mL injection, 1 mL syringe | Is a | mepolizumab 100 mg/mL injection, 1 mL syringe | true | Inferred relationship | Some | ||
| Nucala 100 mg/mL injection, 1 mL syringe | Is a | trade product pack | true | Inferred relationship | Some | ||
| Nucala 100 mg/mL injection, 1 mL syringe | has TP | Nucala | true | Inferred relationship | Some | ||
| Nucala 100 mg/mL injection, 1 mL syringe | has TPUU | Nucala 100 mg/mL injection, 1 mL syringe | true | Inferred relationship | Some | 54636256 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nucala 100 mg/mL injection, 1 mL syringe | Is a | True | Nucala 100 mg/mL injection, 1 mL syringe | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR